TABLE 5.
Patient | Age | Genotype | Steatosis | Congestion | Sinus dilatation | Hepatocyte atrophy | Bridging fibrosis | Nodularity |
---|---|---|---|---|---|---|---|---|
1 | 0.65 | Fin‐maj/c.1166A > G | − | + | + | − | − | − |
2 | 1.1 | Fin‐maj/c.1166A > G | + | +++ | ++ | +++ | + | − |
3 | 1.3 | Fin‐maj/Fin‐maj | − | +++ | ++ | ++ | ++ | − |
4 | 2 | Fin‐maj/Fin‐maj | + | +++ | ++ | ++ | +++ | + |
5 | 2.1 | Fin‐maj/c.1166A > G | − | ++ | − | − | − | − |
6 | 2.6 | Fin‐maj/Fin‐maj | + | ++ | + | − | ++ | − |
7 | 3.5 | Fin‐maj/c.227 T > C | − | ++ | ++ | + | ++ | + |
8 | 12.6 | Fin‐maj/Fin‐maj | − | ++ | ++ | + | + | − |
9 | 13.9 | Fin‐maj/Fin‐maj | + | +++ | ++ | + | +++ | + |
10 | 14.5 | Fin‐maj/Fin‐maj | + | ++ | ++ | + | ++ | + |
11 | 31.1 | Fin‐maj/Fin‐min | + | +++ | + | ++ | + | + |
12 | 31.6 | Fin‐maj/Fin‐maj | + | + | − | + | ++ | + |
13 | 39 | Fin‐maj/Fin‐maj | +++ | ++ | − | − | +++ | ++ |
14 | 41.3 | Fin‐maj/Fin‐maj | − | + | + | + | +++ | +++ |
15 | 48.7 | Fin‐maj/Fin‐maj | ++ | ++ | ++ | +++ | +++ | +++ |
Note: Semi‐quantitative scoring from − to +++. Fin‐major mutation = c.493‐2A > G; Fin‐minor mutation = c.2212delG. Staining, haematoxylin‐eosin.